Ozonised Oil in the Treatment of Glioblastoma
It is with great pleasure that I announce that by popular demand we are resuming our series of video conferences. The next one will be dedicated to a topic that has been reported to us by many of you: Ozonised Oil in the treatment of glioblastoma. Prof. Alberto Izzotti, of the Department of Experimental Medicine of the University of Genoa and of the IRCCS San Martino Polyclinic Hospital, who I had the opportunity to meet last week, will be with us on Thursday 9 November 2023 from 6.00pm to 7.00pm to talk to us about the use of ozonised oil in the treatment of glioblastoma and what scientific research and clinical practice say about it. The event, the ninth of the series, will take place in the usual way: it will open with a very short presentation of the voluntary organization Glioblastoma.IT ODV and its activities, followed by the speech of the speaker and will end as usual with a session open to participants dedicated to questions and answers.
CONFERENCE “OZONIZED OIL IN THE TREATMENT OF GLIOBLASTOMA”
THURSDAY 9 NOVEMBER 2023 6.00pm – 7.00pm
PROGRAMME
18:00-18:10 Dr. Roberto Pugliese – Introduction
18:10-18:40 Prof. Alberto Izzotti – Ozonized Oil in the Treatment of Glioblastoma
18:40-18:55 Questions and Answers
18:55-19:00 Dr. Roberto Pugliese – Conclusion of the work
Two platforms will be used for the event: Zoom and YouTube. The event will also be recorded to make it available and accessible even to those who cannot participate. Links to the zoom event to participate in the conference and to the YouTube channel to follow the event in streaming are shown below.
Link to the video conference on the Zoom platform: >>> Zoom Link. <<<
Link to the video conference streaming on YouTube: >>> YouTube channel. <<<
Would it be possible to provide any type of summary on the conference?
I am a GBM survivor (for now) and am interested in ozone oil. By coincidence I came across a clinical study (from Italy) on the use of ozone against GBM. Here is a link to the study I am referring to: https://www.mdpi.com/2571-841X/6/2/22. This technology is unusual but it seems promising.